Get started
Author

Susan G. Panzer‐Knodle

Observed names: S G Panzer-Knodle, S Panzer-Knodle, S. G. Panzer-Knodle, S. Panzer-Knodle, S.G. Panzer-Knodle, SUSAN G. PANZER‐KNODLE, Susan G Panzer-Knodle, Susan G. Panzer-Knodle, Susan Panzer-Knodle
OpenAlex ID: A5021720106
Assessment of platelet function assays
1998 · Nancy S. Nicholson, Susan G. Panzer-Knodle, et al. · American Heart Journal · 161
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
1993 · Jeffery A. Zablocki, Masateru Miyano, et al. · Journal of Medicinal Chemistry · 106
SC-54684A: An Orally Active Inhibitor of Platelet Aggregation
1995 · Nancy S. Nicholson, Susan G. Panzer-Knodle, et al. · Circulation · 64
A New Model of Dual Interacting Ligand Binding Sites on Integrin αIIbβ3
1999 · Dana D. Hu, Carol A. White, et al. · Journal of Biological Chemistry · 59
Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor
1992 · Jeffery A. Zablocki, Masateru Miyano, et al. · Journal of Medicinal Chemistry · 41
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent
1991 · N.S. Nicholson, S.G. Panzer-Knodle, et al. · Thrombosis Research · 41
Administration of a small molecule tissue factor/Factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time
2003 · James A Szalony, Osman D Suleymanov, et al. · Thrombosis Research · 37
A novel series of orally active antiplatelet agents
1995 · Jeffery A. Zablocki, Foe S. Tjoeng, et al. · Bioorganic & Medicinal Chemistry · 32
Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist
2001 · Nancy S. Nicholson, Norman A. Abood, et al. · Medicinal Research Reviews · 26
Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregation
1993 · Susan Panzer-Knodle, Beatrice B. Taite, et al. · Journal of Pharmacological and Toxicological Methods · 17
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
1990 · N S Nicholson, S G Panzer-Knodle, et al. · Journal of Pharmacology and Experimental Therapeutics · 17
Aminopeptidase resistant Arg‐Gly‐Asp analogs are stable in plasma and inhibit platelet aggregation
1991 · K.AM F. FOK, SUSAN G. PANZER‐KNODLE, et al. · International journal of peptide & protein research · 16
Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents
1994 · P.R. Bovy, F.S. Tjoeng, et al. · Bioorganic & Medicinal Chemistry · 14
SC-49992-A potent and specific inhibitor of platelet aggregation
1994 · Nancy S. Nicholson, Susan G. Panzer-Knodle, et al. · Thrombosis Research · 11
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis.
1993 · L P Feigen, N S Nicholson, et al. · Journal of Pharmacology and Experimental Therapeutics · 8
Calcium channel blockers: correlation among receptor binding, calcium uptake and contractility in vitro.
1987 · S Papaioannou, S Panzer-Knodle, et al. · Journal of Pharmacology and Experimental Therapeutics · 8
Structure-activity relationship studies of RGD analogs containing β-amino acids
1994 · F. S. Tjoeng, P. R. Bovy, et al. · Springer eBooks · 3
Peptide mimetics of the RGD sequence
1992 · F. Siong Tjoeng, Kam F. Fok, et al. · Springer eBooks · 3
Calcium uptake studies of 1,4-dihydropyridine agonists into rabbit aortic smooth muscle cells in culture
1989 · S. Papaioannou, S. Panzer-Knodle, et al. · Life Sciences · 3
Characterization of Binding of an RGD Mimetic, [3H]-SC-52012, to Platelet GPIIb/IIIa
1995 · S. G. Panzer-Knodle, P. Jacqmin, et al. · Platelets · 1
ChemInform Abstract: Orbofiban: An Orally Active GPIIb/IIIa Platelet Receptor Antagonist
2001 · Nancy S. Nicholson, Norman A. Abood, et al. · ChemInform
Design and synthesis of novel RGD analogs using synthetic sweetener models: Implication for sweet taste receptors
1995 · F. S. Tjoeng, M. V. Tóth, et al. · Springer eBooks
Design of orally active, non-peptide fibrinogen receptor antagonists: The evolution process from the RGD sequence to novel anti-platelet aggregation agents
1995 · P. R. Bovy, F. S. Tjoeng, et al. · Springer eBooks
Works count: 23
Citation count: 668
H-index: 13
I10-index: 14
Year
Topic
Type